Loomis Sayles Small/Mid Cap Growth N holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
Loomis Sayles Small/Mid Cap Growth Fund Class N LSMNX
- NAV / 1-Day Return 15.94 / +1.34 %
- Total Assets 194.0M
-
Adj. Expense Ratio
0.830%
- Expense Ratio 0.830%
- Distribution Fee Level Below Average
- Share Class Type Institutional
- Category Small Growth
- Investment Style Small Growth
- Min. Initial Investment 1M
- Status Open
- TTM Yield 0.00
- Turnover 55%
USD | NAV as of Oct 03, 2026 | 1-Day Return as of Oct 03, 2026, 12:11 AM GMT+0
Morningstar’s Analysis LSMNX
Will LSMNX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 18.7
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Fixed Inc Clearing Corp.Repo | 2.76 | 6M | Cash and Equivalents |
Life Time Group Holdings Inc | 2.11 | 5M | Consumer Cyclical |
ATI Inc | 2.10 | 5M | Industrials |
Hinge Health Inc Ordinary Shares - Class A | 1.89 | 4M | Healthcare |
Repligen Corp | 1.86 | 4M | Healthcare |
Charles River Laboratories International Inc | 1.85 | 4M | Healthcare |
Glaukos Corp | 1.81 | 4M | Healthcare |
Enova International Inc | 1.79 | 4M | Financial Services |
Natera Inc | 1.78 | 4M | Healthcare |
Travere Therapeutics Inc Ordinary Shares | 1.76 | 4M | Healthcare |